Intelligent Bio Solutions (INBS) FCF Margin (2020 - 2024)
Intelligent Bio Solutions has reported FCF Margin over the past 5 years, most recently at 296.68% for Q1 2024.
- Quarterly results put FCF Margin at 296.68% for Q1 2024, up 25434.0% from a year ago — trailing twelve months through Mar 2024 was 255.01% (up 10659.0% YoY), and the annual figure for FY2023 was 586.96%, down 37229.0%.
- FCF Margin for Q1 2024 was 296.68% at Intelligent Bio Solutions, up from 375.51% in the prior quarter.
- Over the last five years, FCF Margin for INBS hit a ceiling of 282.57% in Q2 2020 and a floor of 17962.77% in Q1 2021.
- Median FCF Margin over the past 5 years was 386.77% (2021), compared with a mean of 2579.76%.
- Biggest five-year swings in FCF Margin: tumbled -369982bps in 2021 and later skyrocketed 1781097bps in 2022.
- Intelligent Bio Solutions' FCF Margin stood at 274.51% in 2020, then tumbled by -192bps to 801.82% in 2021, then increased by 17bps to 667.5% in 2022, then surged by 44bps to 375.51% in 2023, then increased by 21bps to 296.68% in 2024.
- The last three reported values for FCF Margin were 296.68% (Q1 2024), 375.51% (Q4 2023), and 164.78% (Q3 2023) per Business Quant data.